Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02632448
Title A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Esperas Pharma Inc.
Indications

colorectal cancer

ovarian cancer

sarcoma

Advanced Solid Tumor

triple-receptor negative breast cancer

Therapies

Gemcitabine + LY2880070

LY2880070

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.